Previous Article | Next Article 
Infection and Immunity, May 1999, p. 2649-2652, Vol. 67, No. 5
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Binding of Haemophilus ducreyi to
Extracellular Matrix Proteins
Margaret E.
Bauer,1,* and
Stanley M.
Spinola1,2,3
Departments of
Medicine,1 Microbiology and
Immunology,2 and Pathology and
Laboratory Medicine,3 Indiana University
School of Medicine, Indianapolis, Indiana 46202
Received 19 October 1998/Returned for modification 11 December
1998/Accepted 11 February 1999
 |
ABSTRACT |
We developed an enzyme-linked immunosorbent assay-based assay to
assess Haemophilus ducreyi binding to extracellular matrix (ECM) proteins. H. ducreyi 35000HP bound to fibronectin,
laminin, and type I and III collagen but not to type IV, V, or VI
collagen or elastin. Isogenic strains with mutations in
ftpA or losB bound as well as the parent,
suggesting that neither pili nor full-length lipooligosaccharide is
required for H. ducreyi to bind to ECM proteins.
 |
TEXT |
Haemophilus ducreyi
is the causative agent of chancroid, a sexually transmitted genital
ulcer disease that facilitates the transmission of human
immunodeficiency virus (17). Initiation of H. ducreyi infection requires trauma to the skin (13),
indicating that adherence targets may include subsurface skin
components, such as the extracellular matrix (ECM). Many bacterial
pathogens adhere to ECM proteins via surface structures such as
fimbriae and lipopolysaccharide (LPS), as well as afimbrial surface
proteins (9, 16, 18). To characterize the binding
of H. ducreyi to ECM proteins, we used an
enzyme-linked immunosorbent assay (ELISA)-based assay with ECM
proteins found in adult human skin, including fibronectin, laminin,
several collagens, and elastin. We chose H. ducreyi
35000HP for these studies. Strain 35000HP is a human-passaged
variant of 35000 and is fully virulent in the human challenge model of
chancroid (2). We also examined the roles of two H. ducreyi surface structures, the fine tangled pili and lipooligosaccharide (LOS), in ECM adherence.
ECM protein binding assay.
Microtiter plates (Immulon 4 HBX;
Dynex Technologies, Chantilly, Va.) were coated with ECM proteins by
incubating 100 µl of the appropriate protein, diluted in coating
buffer (0.25 M NaHCO3, 0.25 M
Na2CO3 [pH 9.6]) to 20 µg of protein per ml
or the concentrations indicated below, in assay wells overnight at
4°C (for collagens) or 35°C (for fibronectin and laminin) (8,
12). Wells were then washed three times with phosphate-buffered
saline (PBS) (137 mM NaCl, 2.7 mM KCl, 0.69 mM
KH2PO4, 6.4 mM Na2HPO4
[pH 7.5]) containing 0.05% Tween 20 (PBST), blocked with 300 µl of
10% fetal calf serum in PBST for 2 h at 35°C, and washed three
times in PBS. H. ducreyi 35000HP (2) was
grown in broth with fetal calf serum to mid-log phase as described
previously (6), harvested by centrifugation, and washed and
suspended in PBS to the desired optical density at a wavelength of 660 nm (OD660). Staphylococcus aureus Phillips and
PH100 (gift of Joseph Patti) (10) were grown overnight on
Luria-Bertani agar (11), harvested, washed, and suspended in
PBS. PH100 was supplemented with gentamicin (10 µg/ml). Bacteria
were added to each well, and the plates were incubated at 35°C in 5%
CO2. For bacterial dose-response assays, bacteria were
serially diluted twofold in PBS and tested at concentrations ranging
from an OD660 of 0.8 to 0.003. For ECM dose-response
assays, bacteria were added to all wells at an OD660 of
0.2.
After 4 h, wells were washed three times with PBST to remove
unbound bacteria. Bound H. ducreyi was detected by
incubation overnight with a 1:5,000 dilution of rabbit antiserum
against whole H. ducreyi cells (6), followed by
incubation for 2 to 3 h with horseradish peroxidase-conjugated
goat anti-rabbit secondary antibody (Kirkegaard and Perry Laboratories,
Inc., Gaithersburg, Md.). Bound S. aureus was
detected with a 1:2,000 dilution of polyclonal rabbit antiserum
against whole S. aureus cells (supplied by Lech
Switalski). ELISA plates were incubated with horseradish peroxidase
substrate (SIGMAFAST tablets; Sigma Chemicals, St. Louis, Mo.) for 1 h, and the absorbance at a wavelength of 450 nm
(A450) was measured for each well. Signals of
bound bacteria were calculated as follows: the average
A450 of triplicate test wells
the
average A450 of triplicate control wells. For
each bacterial dose-response assay, control wells were coated with ECM
proteins but received no bacteria; for each protein dose-response assay, control wells received no protein but were incubated with bacteria. To control for bacteria binding nonspecifically to the plates
or to protein, assays were performed in tandem with wells coated with
bovine serum albumin (BSA) or the highly glycosylated serum protein
fetuin at the same concentration as the ECM proteins.
Deposition of ECM proteins and detection of ECM-bound
bacteria.
To confirm that ECM proteins had bound to the ELISA
plates, we probed wells coated with fibronectin, fetuin, and type I,
III, IV, V, and VI collagen (all of human origin; Southern
Biotechnology Associates, Inc., Birmingham, Ala., or Sigma Chemicals)
with S. aureus Phillips and its isogenic cna
mutant PH100. Phillips, known to bind to type I, II, and III
collagen (4, 5), bound to all proteins tested except type
VI collagen (Fig. 1A) and fetuin (Fig. 1B). This binding was dependent on the amount of ECM protein used
to coat the wells (data not shown). PH100, in which the S. aureus collagen adhesin gene, cna, is
insertionally inactivated (10), showed greatly reduced
binding to the panel of collagens (Fig. 1A). These data indicated that
the plates were coated with the ECM proteins and that the assay was
able to distinguish between strains on the basis of their ability to
bind to ECM proteins.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 1.
S. aureus strains binding to ECM
proteins. Error bars indicate standard deviations of triplicate wells.
Data shown are representative of at least three independent assays. (A)
S. aureus Phillips (open symbols) and PH100 (closed
symbols) binding to collagens. Symbols represent binding to type I
(squares), type III (circles), type IV (triangles), type V (diamonds),
and type VI (inverted triangles) collagen. (B) S. aureus Phillips binding to fibronectin and fetuin.
|
|
S. aureus did not bind to laminin (from
Engelbreth-Holm-Swarm mouse sarcoma; Sigma Chemicals), type VI
collagen, or elastin
(bovine, oxalic acid solubilized; Elastin Products
Company, Owensville,
Mo.) (data not shown). To confirm deposition of
these proteins,
we probed ELISA plates coated with serial dilutions of
each protein
or BSA (as a negative control) with antibodies specific
for each
ECM protein (Sigma Chemicals or Rockland, Inc., Gilbertville,
Pa.). Signals that were dependent on the concentration of coated
laminin, type VI collagen, or elastin were obtained (data not
shown).
H. ducreyi binds to specific ECM proteins.
Utilizing the ECM adherence assay, we examined the ability of H. ducreyi 35000HP to bind to human type I, III, IV, V, and VI
collagen, with BSA as a negative control. Strain 35000HP
bound efficiently to type I and III collagen (Fig.
2). This binding varied with the amount
of bacteria (Fig. 2A) and with the amount of collagen (Fig. 2B) used in
the assay. Levels of binding to type IV, V, and VI collagen varied
somewhat, but they were usually in the range of levels of binding to
BSA and were consistently lower than levels of binding to type I and
III collagen (Fig. 2).

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 2.
H. ducreyi 35000HP binding to collagens.
Error bars indicate standard deviations of triplicate wells. Data shown
are representative of at least three independent assays. (A) Bacterial
dose-response assays; (B) protein dose-response assays.
|
|
We next tested the ability of 35000HP to bind to fibronectin and
laminin, using fetuin as a negative control. Strain 35000HP
bound to
both fibronectin and laminin in a dose-dependent fashion,
while binding
to fetuin was uniformly low, regardless of the amount
of bacteria or
fetuin in the assay (Fig.
3). We also
tested 35000HP
for adherence to elastin and observed no binding (data
not shown).

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 3.
H. ducreyi 35000HP binding to ECM
proteins. Error bars indicate standard deviations of triplicate wells.
Data shown are representative of at least three independent assays. (A)
Bacterial dose-response assays; (B) protein dose-response assays.
|
|
We tested several parameters in optimizing the assay for
H. ducreyi. Protein dose-response assays showed that coating
wells
with 2 µg of ECM glycoprotein per well was sufficient for
maximal
binding signals (Fig.
2B and
3B). We also tested 35000HP
binding
to each ECM protein over time, with incubation periods ranging
from 1 to 8 h. Binding signals peaked at 4 h and were not
enhanced
by further incubation (data not shown). We compared ECM
binding
signals of broth-grown cells, harvested at mid-logarithmic,
late
logarithmic, and stationary phases, with those of cells grown
overnight on agar plates. While the results were qualitatively
identical, broth-grown cells yielded much higher overall signal
levels than plate-grown cells (data not shown). No differences
were
observed among the differentially harvested broth-grown cells,
indicating that the adhesin(s) responsible appears to be constitutively
expressed under the growth conditions tested. Mid-log phase,
broth-grown
cells were used for all subsequent
assays.
In a previous study by Abeck et al., a panel of
H. ducreyi strains was tested for the ability to agglutinate latex
beads coated
with fibronectin, type III collagen, or laminin
(
1). The researchers
reported that a single concentration of
H. ducreyi agglutinated
beads coated with a single
concentration of each of these proteins
but not with ovalbumin. There
was little difference among the
strains tested. However,
H. ducreyi forms tight intercellular
junctions that cause
autoaggregation, which could affect the interpretation
of the results
of a particle agglutination assay. The ELISA format
provides a more
objective readout than the agglutination assay
and allows for
processing many samples at once, thus permitting
multiple strains and
ECM proteins to be tested concurrently in
dose-response
assays.
The observed pattern of
H. ducreyi 35000HP binding to
collagens (Fig.
2) indicates some specificity for
H. ducreyi adherence
to type I and III collagen. Strain 35000HP also
bound to fibronectin
and laminin but not elastin. In this assay, we
detected binding
only to immobilized ECM proteins, so we cannot exclude
the possibility
that
H. ducreyi binds to type IV, V, or
VI collagen or elastin
either in solution or in
vivo.
ECM binding is not mediated by FtpA.
H. ducreyi
expresses a fine tangled pilus, the major subunit of which is FtpA
(3). Pili of several bacterial species have been shown to
bind specifically to ECM proteins (7, 15, 19), and one
report indicated a correlation between piliation of H. ducreyi and binding to laminin (1). To examine the role
of the H. ducreyi pilus in ECM binding, we tested the
ability of 35000HP-SMS1 [an isogenic mutant of 35000HP in which
ftpA, which encodes the major subunit of the fine tangled
pili, is insertionally inactivated by mTn3(Cm)] to bind to
fibronectin, laminin, and type I and III collagen. Strain 35000HP-SMS1
bound as well as 35000HP to each of these proteins (data not shown).
Neither strain bound to type IV collagen or fetuin. The kinetics of ECM
binding were also unaffected by the mutation in ftpA (data
not shown). These data indicate that FtpA is not required for adherence
to ECM proteins, although we cannot rule out a contributory role for
FtpA in conjunction with other adhesins. These data confirm those of
Brentjens et al., who reported that both strain 35000 and an isogenic
ftpA derivative bind to laminin (3), and
contradict those of Abeck et al., who reported that strain 35000 does
not bind to laminin and that piliation is required for laminin binding (1). These discrepancies could be due to differences in the assays or in the strains tested.
Full-length LOS is not required for ECM binding.
Another
surface structure that can mediate ECM binding is LPS.
Helicobacter pylori LPS binds specifically to laminin
(16). This activity is most likely mediated by the core
sugars, although the specific saccharides involved are unknown. We
examined the role of full-length H. ducreyi LOS in ECM
binding by testing 35000HP-RSM2 (gift of Robert S. Munson, Jr.),
an isogenic losB mutant of 35000HP, for binding to the
panel of ECM proteins. The major LOS saccharide chain
produced by 35000HP-RSM2 consists of a single glucose attached to a
heptose trisaccharide core and 2-keto-deoxyoctulosonic acid and cannot
be sialylated. The mutation in losB in 35000HP-RSM2 had no
effect on binding to collagens, fibronectin, or laminin (data not
shown). Thus, neither the terminal oligosaccharide nor sialylation is
required for the observed ECM binding by H. ducreyi. However, these data do not rule out a role for the remaining core sugars expressed in the LOS moiety of the losB mutant.
In summary, we demonstrated that
H. ducreyi
35000HP binds to fibronectin, laminin, and type I and III collagen in a
dose-dependent
manner. These ECM proteins are found throughout
the skin and may
serve as attachment and colonization sites for
H. ducreyi in infection.
These results suggest that
H. ducreyi may express multiple ECM-binding
adhesins.
Alternatively,
H. ducreyi may express a multifunctional
adhesin, such as YadA of
Yersinia enterocolitica
(
14), in which
different domains bind to different ECM
proteins. The observed
binding does not require FtpA or
full-length LOS. Work to identify
a specific ECM-binding
adhesin(s) in
H. ducreyi is currently under
way.
 |
ACKNOWLEDGMENTS |
We thank Steven Clegg and Tricia Sebghati for technical
advice and prepublication sharing of protocols. We thank Joseph
Patti for supplying the S. aureus strains, Robert
S. Munson, Jr., for supplying 35000HP-RSM2, and Lech Switalski for
supplying S. aureus-specific antiserum. We thank Byron
Batteiger for helpful critique of the manuscript.
This work was supported by Public Health Service grant AI27863 from the
National Institute of Allergy and Infectious Diseases. M.E.B. was
supported by Public Health Service grant AI09971 from the National
Institute of Allergy and Infectious Diseases.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Indiana
University School of Medicine, Emerson Hall 435, 545 Barnhill Dr.,
Indianapolis, IN 46202. Phone: (317) 274-8143. Fax: (317) 274-1587. E-mail: mebauer{at}iupui.edu.
Editor:
P. E. Orndorff
 |
REFERENCES |
| 1.
|
Abeck, D.,
A. P. Johnson, and H. Mensing.
1992.
Binding of Haemophilus ducreyi to extracellular matrix proteins.
Microb. Pathog.
13:81-84[Medline].
|
| 2.
|
Al-Tawfiq, J. A.,
A. C. Thornton,
B. P. Katz,
K. R. Fortney,
K. D. Todd,
A. F. Hood, and S. M. Spinola.
1998.
Standardization of the experimental model of Haemophilus ducreyi infection in human subjects.
J. Infect. Dis.
178:1684-1687[Medline].
|
| 3.
|
Brentjens, R. J.,
M. Ketterer,
M. A. Apicella, and S. M. Spinola.
1996.
Fine tangled pili expressed by Haemophilus ducreyi are a novel class of pili.
J. Bacteriol.
178:808-816[Abstract/Free Full Text].
|
| 4.
|
Hienz, S. A.,
M. Palma, and J.-I. Flock.
1996.
Insertional inactivation of the gene for collagen-binding protein has a pleiotropic effect on the phenotype of Staphylococcus aureus.
J. Bacteriol.
178:5327-5329[Abstract/Free Full Text].
|
| 5.
|
Hienz, S. A.,
T. Schennings,
A. Heimdahl, and J. Flock.
1996.
Collagen binding of Staphylococcus aureus is a virulence factor in experimental endocarditis.
J. Infect. Dis.
174:83-88[Medline].
|
| 6.
|
Hiltke, T. J.,
M. E. Bauer,
J. Klesney-Tait,
E. J. Hansen,
R. S. Munson, Jr., and S. M. Spinola.
1999.
Effect of normal and immune sera on Haemophilus ducreyi 35000HP and its isogenic MOMP and LOS mutants.
Microb. Pathog.
26:93-102[Medline].
|
| 7.
|
Kukkonen, M.,
T. Raunio,
R. Virkola,
K. Lahteenmaki,
P. H. Makela,
P. Klemm,
S. Clegg, and T. K. Korhonen.
1993.
Basement membrane carbohydrate as a target for bacterial adhesion: binding of type 1 fimbriae of Salmonella enterica and Escherichia coli to laminin.
Mol. Microbiol.
7:229-237[Medline].
|
| 8.
|
Ljungh, A., and T. Wadstrom.
1995.
Binding of extracellular matrix proteins by microbes.
Methods Enzymol.
253:501-514[Medline].
|
| 9.
|
Ljungh, A., and T. Wadstrom.
1996.
Interactions of bacterial adhesions with the extracellular matrix, p. 129-140.
In
I. Kahane, and I. Ofek (ed.), Toward anti-adhesion therapy for microbial diseases. Plenum Press, New York, N.Y.
|
| 10.
|
Patti, J. M.,
T. Bremell,
D. Krajewska-Pietrasik,
A. Abdelnour,
A. Tarkowski,
C. Rydén, and M. Höök.
1994.
The Staphylococcus aureus collagen adhesion is a virulence determinant in experimental septic arthritis.
Infect. Immun.
62:152-161[Abstract/Free Full Text].
|
| 11.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 12.
|
Sebghati, T. A. S.,
T. K. Korhonen,
D. B. Hornick, and S. Clegg.
1998.
Characterization of the type 3 fimbrial adhesins of Klebsiella strains.
Infect. Immun.
66:2887-2894[Abstract/Free Full Text].
|
| 13.
|
Spinola, S. M.,
L. M. Wild,
M. A. Apicella,
A. A. Gaspari, and A. A. Campagnari.
1994.
Experimental human infection with Haemophilus ducreyi.
J. Infect. Dis.
169:1146-1150[Medline].
|
| 14.
|
Tamm, A.,
A. M. Tarkkanen,
T. K. Korhonen,
P. Kuusela,
P. Toivanen, and M. Skurnik.
1993.
Hydrophobic domains affect the collagen-binding specificity and surface polymerization as well as the virulence potential of the YadA protein of Yersinia enterocolitica.
Mol. Microbiol.
10:995-1011[Medline].
|
| 15.
|
Tarkkanen, A. M.,
B. L. Allen,
B. Westerlund,
H. Holthofer,
P. Kuusela,
L. Risteli,
S. Clegg, and T. K. Korhonen.
1990.
Type V collagen as the target for type-3 fimbriae, enterobacterial adherence organelles.
Mol. Microbiol.
4:1353-1361[Medline].
|
| 16.
|
Valkonen, K. H.,
T. Wadström, and A. P. Moran.
1994.
Interaction of lipopolysaccharides of Helicobacter pylori with basement membrane protein laminin.
Infect. Immun.
62:3640-3648[Abstract/Free Full Text].
|
| 17.
|
Wasserheit, J. N.
1992.
Epidemiological synergy. Interrelationship between human immunodeficiency virus infection and other sexually transmitted diseases.
Sex. Transm. Dis.
19:61-77[Medline].
|
| 18.
|
Westerlund, B., and T. K. Korhonen.
1993.
Bacterial proteins binding to the mammalian extracellular matrix.
Mol. Microbiol.
9:687-694[Medline].
|
| 19.
|
Westerlund, B.,
P. Kuusela,
J. Risteli,
L. Risteli,
T. Vartio,
H. Rauvala,
R. Virkola, and T. K. Korhonen.
1989.
The 075X adhesion of uropathogenic Escherichia coli is a type IV collagen-binding protein.
Mol. Microbiol.
3:329-337[Medline].
|
Infection and Immunity, May 1999, p. 2649-2652, Vol. 67, No. 5
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Leduc, I., White, C. D., Nepluev, I., Throm, R. E., Spinola, S. M., Elkins, C.
(2008). Outer Membrane Protein DsrA Is the Major Fibronectin-Binding Determinant of Haemophilus ducreyi. Infect. Immun.
76: 1608-1616
[Abstract]
[Full Text]
-
Dabo, S. M., Confer, A. W., Anderson, B. E., Gupta, S.
(2006). Bartonella henselae Pap31, an Extracellular Matrix Adhesin, Binds the Fibronectin Repeat III13 Module.. Infect. Immun.
74: 2513-2521
[Abstract]
[Full Text]
-
Fulcher, R. A., Cole, L. E., Janowicz, D. M., Toffer, K. L., Fortney, K. R., Katz, B. P., Orndorff, P. E., Spinola, S. M., Kawula, T. H.
(2006). Expression of Haemophilus ducreyi Collagen Binding Outer Membrane Protein NcaA Is Required for Virulence in Swine and Human Challenge Models of Chancroid.. Infect. Immun.
74: 2651-2658
[Abstract]
[Full Text]
-
Ward, C. K., Mock, J. R., Hansen, E. J.
(2004). The LspB Protein Is Involved in the Secretion of the LspA1 and LspA2 Proteins by Haemophilus ducreyi. Infect. Immun.
72: 1874-1884
[Abstract]
[Full Text]
-
Vakevainen, M., Greenberg, S., Hansen, E. J.
(2003). Inhibition of Phagocytosis by Haemophilus ducreyi Requires Expression of the LspA1 and LspA2 Proteins. Infect. Immun.
71: 5994-6003
[Abstract]
[Full Text]
-
Ward, C. K., Latimer, J. L., Nika, J., Vakevainen, M., Mock, J. R., Deng, K., Blick, R. J., Hansen, E. J.
(2003). Mutations in the lspA1 and lspA2 Genes of Haemophilus ducreyi Affect the Virulence of This Pathogen in an Animal Model System. Infect. Immun.
71: 2478-2486
[Abstract]
[Full Text]
-
Patterson, K., Olsen, B., Thomas, C., Norn, D., Tam, M., Elkins, C.
(2002). Development of a Rapid Immunodiagnostic Test for Haemophilus ducreyi. J. Clin. Microbiol.
40: 3694-3702
[Abstract]
[Full Text]
-
Nika, J. R., Latimer, J. L., Ward, C. K., Blick, R. J., Wagner, N. J., Cope, L. D., Mahairas, G. G., Munson, R. S. Jr., Hansen, E. J.
(2002). Haemophilus ducreyi Requires the flp Gene Cluster for Microcolony Formation In Vitro. Infect. Immun.
70: 2965-2975
[Abstract]
[Full Text]
-
Ahmed, H. J., Johansson, C., Svensson, L. A., Ahlman, K., Verdrengh, M., Lagergard, T.
(2002). In Vitro and In Vivo Interactions of Haemophilusducreyi with Host Phagocytes. Infect. Immun.
70: 899-908
[Abstract]
[Full Text]
-
Bauer, M. E., Goheen, M. P., Townsend, C. A., Spinola, S. M.
(2001). Haemophilus ducreyi Associates with Phagocytes, Collagen, and Fibrin and Remains Extracellular throughout Infection of Human Volunteers. Infect. Immun.
69: 2549-2557
[Abstract]
[Full Text]
-
Bong, C. T. H., Throm, R. E., Fortney, K. R., Katz, B. P., Hood, A. F., Elkins, C., Spinola, S. M.
(2001). DsrA-Deficient Mutant of Haemophilus ducreyi Is Impaired in Its Ability To Infect Human Volunteers. Infect. Immun.
69: 1488-1491
[Abstract]
[Full Text]
-
Bauer, M. E., Spinola, S. M.
(2000). Localization of Haemophilus ducreyi at the Pustular Stage of Disease in the Human Model of Infection. Infect. Immun.
68: 2309-2314
[Abstract]
[Full Text]